Antibody prevalence after three or more COVID-19 vaccine doses in individuals who are immunosuppressed in the UK: a cross-sectional study from MELODY (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(23)00160-1
Publication URI: http://dx.doi.org/10.1016/s2665-9913(23)00160-1
Type: Journal Article/Review
Parent Publication: The Lancet Rheumatology
Issue: 8